An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Clinical trial NCT06401356 · RECRUITING

Trial details

NCT number: NCT06401356
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hematologic Malignancy Solid Tumor Advanced Malignancies

Start date: 2024-08-13
Primary completion: 2027-06-02
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.